AAPL 250.9362 1.1636% MSFT 439.85 0.5624% NVDA 132.26 2.5987% GOOGL 190.36 1.0403% GOOG 191.585 0.7547% AMZN 224.7026 1.8967% META 605.1 1.3245% AVGO 221.57 -0.9167% TSLA 434.8 -1.211% TSM 195.3 -0.133% LLY 758.87 -0.7637% V 315.9 1.9756% JPM 234.325 1.7168% UNH 493.79 -1.1867% NVO 103.7 -2.1329% WMT 93.89 0.3634% LVMUY 130.52 0.7721% XOM 105.67 -0.7048% LVMHF 649.5 0.6649% MA 526.755 1.3068%

4Front Ventures Corp

Healthcare US FFNTF

0.022USD
-0.011(33.33%)

Last update at 2024-12-19T18:53:00Z

Day Range

0.020.02
LowHigh

52 Week Range

0.070.31
LowHigh

Fundamentals

  • Previous Close 0.03
  • Market Cap66.82M
  • Volume64150
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-35.13800M
  • Revenue TTM115.20M
  • Revenue Per Share TTM0.18
  • Gross Profit TTM 41.15M
  • Diluted EPS TTM-0.11

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2023-04-30 2022-04-30 2021-04-30 2020-04-30 2019-04-30
Type yearly yearly yearly yearly yearly
Date 2023-04-30 2022-04-30 2021-04-30 2020-04-30 2019-04-30
Income before tax -36.97000M -24.35800M -44.94300M -179.52900M -52.59253M
Minority interest -0.02100M -0.02000M 0.05M -0.01700M -1.66800M
Net income -46.89800M -38.30900M -47.05100M -180.60300M -52.55353M
Selling general administrative 62.80M 58.40M 48.97M 44.30M 12.42M
Selling and marketing expenses - - - - -
Gross profit 41.15M 49.40M 36.51M 14.02M 10.19M
Reconciled depreciation 3.19M 6.64M 8.56M 5.14M 2.00M
Ebit -24.83600M -14.10600M -16.52400M -32.56400M -12.20400M
Ebitda -21.09700M -4.01800M -20.60100M -167.91400M -46.05373M
Depreciation and amortization - - - - -
Non operating income net other - - - - 0.00000M
Operating income -24.83600M -14.10600M -16.52400M -34.41700M -4.67618M
Other operating expenses - - - 0.34M 0.00000M
Interest expense 12.69M 13.70M 15.78M 6.47M 4.54M
Tax provision 9.91M 13.93M 15.05M 1.38M -0.03900M
Interest income 0.03M 0.01M 0.72M 0.42M 0.39M
Net interest income -12.65300M -13.68900M -15.05900M -6.04800M -4.14770M
Extraordinary items - - - - 0.00000M
Non recurring - - - - 0.00000M
Other items - - - - 0.00000M
Income tax expense 9.91M 13.93M 15.05M 0.97M 0.10M
Total revenue 118.58M 104.57M 57.63M 31.13M 13.94M
Total operating expenses 143.41M 118.67M 74.16M 65.54M 18.61M
Cost of revenue 77.43M 55.17M 21.12M 17.11M 3.75M
Total other income expense net 0.52M 3.44M -13.36000M -139.06400M -43.76865M
Discontinued operations - - 12.99M -3.13300M -3.13300M
Net income from continuing ops -46.87700M -38.28900M -59.99200M -180.90600M -52.55353M
Net income applicable to common shares -46.89800M -38.30900M -47.05100M -182.01000M -8.74800M
Preferred stock and other adjustments - - - - 0.00000M
Breakdown 2023-04-30 2022-04-30 2021-04-30 2020-04-30 2019-04-30
Type yearly yearly yearly yearly yearly
Date 2023-04-30 2022-04-30 2021-04-30 2020-04-30 2019-04-30
Total assets 344.73M 255.54M 204.76M 203.92M 62.52M
Intangible assets 30.93M 26.25M 28.79M 41.44M 0.00000M
Earning assets - - - - -
Other current assets 1.21M - - 2.19M 0.99M
Total liab 316.38M 218.01M 162.55M 127.94M 72.49M
Total stockholder equity 28.26M 37.46M 42.15M 76.18M -9.96490M
Deferred long term liab - - - - 0.00000M
Other current liab 0.37M 27.47M 19.70M 2.36M 0.88M
Common stock 304.60M 274.12M 250.58M 252.66M 68.96M
Capital stock 304.60M 274.12M 250.58M 252.66M 32.66M
Retained earnings -335.75500M -288.85700M -250.54800M -203.49700M -21.48700M
Other liab 11.64M 11.44M 11.23M 6.31M 0.23M
Good will 53.95M 23.16M 23.16M 33.99M 0.00000M
Other assets 11.23M 12.11M 11.99M 33.69M 2.18M
Cash 15.19M 22.58M 18.93M 5.79M 10.64M
Cash and equivalents - - - - -
Total current liabilities 77.45M 48.84M 37.78M 18.85M 12.16M
Current deferred revenue - - - - -
Net debt 68.97M 48.23M 48.08M 83.39M 3.50M
Short term debt - - - - 0.00000M
Short long term debt 9.06M 6.20M 5.02M 7.38M 0.00000M
Short long term debt total - - - - -
Other stockholder equity - - - 25.62M 2.23M
Property plant equipment 195.36M 143.15M 96.08M 62.58M 19.85M
Total current assets 53.27M 50.87M 44.74M 30.24M 10.48M
Long term investments - - 0.00000M 0.76M 1.15M
Net tangible assets -56.62400M -11.94100M -9.79400M -0.65300M 21.74M
Short term investments - - - - 0.00000M
Net receivables 11.28M 5.97M 5.49M 12.43M 3.93M
Long term debt 75.11M 64.62M 61.99M 81.80M 14.14M
Inventory 25.59M 20.09M 18.04M 9.82M 4.84M
Accounts payable 12.70M 2.13M 4.72M 5.87M 2.04M
Total permanent equity - - - - 0.00000M
Noncontrolling interest in consolidated entity - - - - 0.00000M
Temporary equity redeemable noncontrolling interests - - - - 0.00000M
Accumulated other comprehensive income - - - - 0.00000M
Additional paid in capital - - - - 0.00000M
Common stock total equity - - - - 0.00000M
Preferred stock total equity - - - - 0.00000M
Retained earnings total equity - - - - 0.00000M
Treasury stock - - - - 0.00000M
Accumulated amortization - - - - 0.00000M
Non currrent assets other - - - 2.35M 33.27M
Deferred long term asset charges - - - - 0.00000M
Non current assets total 291.46M 204.66M 160.02M 172.18M 33.27M
Capital lease obligations 140.66M 96.74M 53.45M 21.95M 0.00000M
Long term debt total - - - - 0.00000M
Breakdown 2023-04-30 2022-04-30 2021-04-30 2020-04-30 2019-04-30
Type yearly yearly yearly yearly yearly
Date 2023-04-30 2022-04-30 2021-04-30 2020-04-30 2019-04-30
Investments -26.86700M -13.01400M 39.34M -19.49800M -17.29801M
Change to liabilities 9.31M 0.00000M 3.08M 2.35M 0.51M
Total cashflows from investing activities -26.86700M -13.01400M 39.34M -19.49900M -30.98900M
Net borrowings 10.62M 8.63M -31.49400M 53.60M -0.46100M
Total cash from financing activities 10.71M 10.89M -14.50500M 53.60M 42.00M
Change to operating activities 3.99M 3.99M 1.80M 1.45M -3.90200M
Net income -46.89800M -38.30900M -47.05100M -182.01000M -8.74800M
Change in cash -7.39100M 3.65M 10.79M 6.71M -2.22400M
Begin period cash flow 22.58M 18.93M 8.14M 1.44M 11.86M
End period cash flow 15.19M 22.58M 18.93M 5.79M 10.64M
Total cash from operating activities 8.77M 5.78M -14.04100M -27.39400M -13.23100M
Issuance of capital stock - - - 0.00000M 0.00000M
Depreciation 8.34M 6.64M 8.56M 4.17M 0.55M
Other cashflows from investing activities 0.11M -0.23500M 27.79M -7.13600M 0.37M
Dividends paid - - - - 0.00000M
Change to inventory 0.06M -2.05000M -9.15900M -4.07600M -1.81000M
Change to account receivables -4.42600M -4.42600M -0.78100M 1.19M 0.01M
Sale purchase of stock - - - 0.00000M 0.00000M
Other cashflows from financing activities - -1.20100M 3.50M 3.50M -0.56300M
Change to netincome 25.78M 25.78M 18.92M 148.87M -0.09500M
Capital expenditures 2.43M 13.87M 13.88M 20.91M 9.88M
Change receivables - - - - 0.00000M
Cash flows other operating - - - - 0.00000M
Exchange rate changes - - - - 0.00000M
Cash and cash equivalents changes - - - - 0.00000M
Change in working capital 21.54M 7.64M 5.53M 0.55M -2.96942M
Stock based compensation 7.21M 10.08M 5.31M 5.91M 4.35M
Other non cash items 12.90M 18.01M 5.84M 2.52M 4.28M
Free cash flow 6.33M -8.09500M -27.91600M -48.05500M -3.83055M

Peer Comparison

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
FFNTF
4Front Ventures Corp
-0.011 33.33% 0.02 - 10.99 0.58 3.31 2.35 -4.932
ZTS
Zoetis Inc
-2.975 1.78% 164.03 40.18 30.96 10.67 17.60 11.27 26.18
MKKGY
Merck KGaA ADR
-0.12 0.42% 28.66 21.25 14.93 3.10 2.14 3.60 12.98
MKGAF
MERCK Kommanditgesellschaft auf Aktien
-1.925 1.33% 142.50 21.73 14.95 3.16 2.15 3.56 12.82
TAK
Takeda Pharmaceutical Co Ltd ADR
-0.07 0.53% 13.04 32.67 11.53 0.01 0.87 0.02 0.07

Reports Covered

Stock Research & News

Profile

4Front Ventures Corp. owns and manages licensed cannabis facilities in state-licensed markets in the United States. The company operates in two segments, THC Cannabis and CBD Wellness. THC Cannabis segment engages in the cultivation, production, manufacturing, and distribution of THC cannabis products to owned dispensaries and third party retailers; and provision of ancillary services. This segment also sells equipment, supplies, and intellectual property to cannabis producers; and leases real estate properties. In addition, it operates dispensaries in the Massachusetts, Illinois, and Michigan primarily under the MISSION brand name. The CBD Wellness segment sells non-THC hemp derived products. 4Front Ventures Corp. was founded in 2011 and is based in Phoenix, Arizona.

4Front Ventures Corp

5060 North 40th Street, Phoenix, AZ, United States, 85018

Key Executives

Name Title Year Born
Mr. Leonid Gontmakher CEO & Non Independent Director 1987
Mr. Andrew Fisher Thut Chief Investment Officer & Corp. Sec. 1974
Mr. Karl Chowscano Pres NA
Mr. Kristopher Tutundjian Krane Co-Founder & Strategic Advisor 1979
Mr. Keith Adams Chief Financial Officer 1959
Mr. Christopher Wimmer Gen. Counsel NA
Ms. Jill Vipond VP of HR NA
Mr. Gabe Mendoza Exec. VP of Retail Operations NA
Ms. Tera Martin Chief of Staff NA
Mr. Raymond Landgraf Pres of California Operations NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.